Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:931-932 (18 October), doi:10.1136/bmj.327.7420.931-c
| The first 150 words of the full text of this article appear below. |
EDITORThe editorial by Boos et al reaffirms that rate control is not inferior to rhythm control in preventing death and morbidity due to cardiovascular causes in atrial fibrillation.1 However, this information should not be extrapolated to critically ill medical and surgical patients.
Atrial arrythmias are common in critically ill patients and are often associated with cardiorespiratory instability and increased mortality. Both rate and rhythm control in the acute and short term is crucial in managing these patients. Atrial arrythmia in critically ill patients is usually multifactorial, and often the antiarrhythmic drugs do not need to be continued beyond the critical care unit unless there is a strong case to do so. Amiodarone, diltiazem, and magnesium infusions,
blockers, and procianamide are safe and efficacious in achieving this goal.2-4
Direct current cardioversion is not useful in achieving sustained rate or rhythm control in critically ill patients.5 Amiodarone magnesium still remains
Egbert Pravinkumar, lecturer
Academic Department of Intensive Care, Institute of Medical Sciences, Aberdeen AB25 2ZD e.pravinkumar@abdn.ac.uk